North America Immunohistochemistry Market Forecast 2018-2026

Publisher Name :
Date: 09-Apr-2018
No. of pages: 88

Key Findings

The North America immunohistochemistry market is growing significantly at 8.01% of CAGR from 2018 to 2026. The immunohistochemistry market is developing majorly due to the growing prevalence of autoimmune disease especially in the young girls along with women of all age groups up to 64 years.

Market Insights

North America holds the highest market share in the global immunohistochemistry market. This growth of the market is attributed to the rising healthcare cost in the region. The major countries in the North America region are the United States and Canada. The United States is the highest contributor to the North America immunohistochemistry market. Increasing cases of cancer in the country is one of the major reasons for the growth of the market in the country. In Canada, common types of cancer are lung, breast, colorectal and prostate. This upsurge is advancing the demand for IMS in the region.

Competitive Insights

The leading players in the market are Merck Millipore, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Siemens Ag Healthcare, Danaher Corporation, Cell Signaling Technology Inc., Agilent Technologies Inc., Histologix, Abbott Laboratories, F. Hoffmann-La Roche Ag, Abcam Plc, Biogenex, Perkinelmer, Inc., and Bio Sb.

North America Immunohistochemistry Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Reagents Products Are Growing At A Significant Rate
3.2.2. Diagnostics Are The Majorly Used Application In The Market
3.2.3. Hospitals And Diagnostic Laboratories Holds The Largest Market Share In The End-Users Market
4. Market Determinants
4.1. Market Drivers
4.1.1. Rising Cancer Incidence
4.1.2. Technological Expansions In In-Vitro Diagnostic Commerce
4.1.3. Increasing Healthcare Spending
4.1.4. Growing Popularity of Poc Testing
4.2. Market Restraints
4.2.1. Insurance Coverage And Reimbursement Issues
4.2.2. Limitations of Closed Systems
4.2.3. Presence of An Undiagnosed Population
4.3. Market Opportunities
4.3.1. Use of Biomarkers For Disease Diagnosis And Increasing Efficiency
4.3.2. Paradigm Shift Toward Precision Diagnosis Through Personalized Medicine
4.3.3. Advancements In Technologies
4.4. Market Challenges
4.4.1. High Initial Investment And Maintenance Cost
4.4.2. Stringent Regulation For Approval of Devices
4.4.3. Pricing Pressure Coupled With Lack of Product Differentiation
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Antibodies
5.1.1.1. Primary Antibodies
5.1.1.2. Secondary Antibodies
5.1.2. Equipment
5.1.2.1. Slide Staining Systems
5.1.2.2. Tissue Microarrays
5.1.2.3. Tissue Processing Systems
5.1.2.4. Slide Scanners
5.1.2.5. Other Equipment's
5.1.3. Reagents
5.1.3.1. Histological Stains
5.1.3.2. Blocking Sera And Reagents
5.1.3.3. Chromogenic Substrates
5.1.3.4. Fixation Reagents
5.1.3.5. Stabilizers
5.1.3.6. Organic Solvents
5.1.3.7. Proteolytic Enzymes
5.1.3.8. Diluents
5.1.4. Kits
5.2. Market By Applications 2018-2026
5.2.1. Diagnostics
5.2.1.1. Cancer
5.2.1.2. Infectious Diseases
5.2.1.3. Cardiovascular Disease
5.2.1.4. Autoimmune Diseases
5.2.1.5. Diabetes Mellitus
5.2.1.6. Nephrological Diseases
5.2.2. Drug Testing
5.3. Market By End-Users 2018-2026
5.3.1. Hospitals And Diagnostic Laboratories
5.3.2. Research Institutes
5.3.3. Other End-Users
6. Key Analytics
6.1. Immunohistochemistry Etymology
6.2. Regulatory Frameworks
6.2.1. Regulations In The United States
6.3. Value Chain Analysis
6.3.1. Raw Material Suppliers
6.3.2. Manufacturers
6.3.3. Distributors
6.3.4. End-Users
6.4. Opportunity Matrix
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Company Profile
8.1.2. Product Portfolio
8.1.3. Swot Analysis
8.1.4. Strategic Initiatives
8.2. Abcam Plc
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Strategic Initiatives
8.3. Agilent Technologies, Inc.
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Biogenex
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Strategic Initiatives
8.5. Bio-Rad Laboratories, Inc.
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiative
8.6. Bio Sb
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Strategic Initiatives
8.7. Cell Signaling Technology, Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Danaher Corporation
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. F. Hoffmann-La Roche Ag
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Histologix
8.10.1. Company Overview
8.10.2. Product Portfolio
8.11. Merck Millipore
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Strategic Initiatives
8.12. Perkinelmer, Inc.
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Siemens Ag Healthcare
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Swot Analysis
8.13.4. Strategic Initiatives
8.14. Thermo Fisher Scientific Inc.
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives

List of Tables

Table 1 North America Immunohistochemistry Market 2018-2026 ($ Million)
Table 2 Cancer Markers Used In Diagnosis And Treatment
Table 3 Population Aged 60 Years And Above
Table 4 Population Aged 80 Years And Above
Table 5 North America Immunohistochemistry Market By Products 2018-2026 ($ Million)
Table 6 North America Immunohistochemistry Market In Antibodies 2018-2026 ($ Million)
Table 7 Incidence of Diabetes In Major Countries, 2016 ($ Millions)
Table 8 North America Immunohistochemistry Market In Antibodies -2026 ($ Million)
Table 9 North America Antibodies Market In Primary Antibodies 2018-2026 ($ Million)
Table 10 Clinically Important Monoclonal Antibodies
Table 11 North America Antibodies Market In Secondary Antibodies Geography 2018-2026 ($ Million)
Table 12 Secondary Antibody Selection
Table 13 North America Immunohistochemistry Market In Equipment 2018-2026 ($ Million)
Table 14 North America Immunohistochemistry Market In Equipment By Type 2018-2026 ($ Million)
Table 15 North America Equipment Market In Slide Staining Systems 2018-2026 ($ Million)
Table 16 North America Equipment Market In Tissue Microarrays 2018-2026 ($ Million)
Table 17 North America Equipment Market In Tissue Processing Systems 2018-2026 ($ Million)
Table 18 North America Equipment Market In Slide Scanners 2018-2026 ($ Million)
Table 19 North America Equipment Market In Other Equipment's 2018-2026 ($ Million)
Table 20 North America Immunohistochemistry Market In Reagents 2018-2026 ($ Million)
Table 21 North America Immunohistochemistry Market In Reagents 2018-2026 ($ Million)
Table 22 North America Reagents Market In Histological Stains 2018-2026 ($ Million)
Table 23 Histology Stains And Its Categories
Table 24 North America Reagents Market In Blocking Sera And Reagents 2018-2026 ($ Million)
Table 25 North America Reagents Market In Chromogenic Substrates 2018-2026 ($ Million)
Table 26 North America Reagents Market In Fixation Reagents 2018-2026 ($ Million)
Table 27 Common Fixatives And Their General Target Antigens
Table 28 North America Reagents Market In Stabilizers 2018-2026 ($ Million)
Table 29 North America Reagents Market In Organic Solvents 2018-2026 ($ Million)
Table 30 North America Reagents Market In Proteolytic Enzymes 2018-2026 ($ Million)
Table 31 North America Reagents Market In Diluents 2018-2026 ($ Million)
Table 32 North America Immunohistochemistry Market In Kits 2018-2026 ($ Million)
Table 33 Available Kit Components For Ihc Optimization
Table 34 North America Immunohistochemistry Market By Application 2018-2026 ($ Million)
Table 35 North America Immunohistochemistry Market In Diagnostic 2018-2026 ($ Million)
Table 36 North America Immunohistochemistry Market In Diagnostic 2018-2026 ($ Million)
Table 37 North America Diagnostic Market In Cancer 2018-2026 ($ Million)
Table 38 North America Diagnostic Market In Infectious Diseases 2018-2026 ($ Million)
Table 39 North America Diagnostic Market In Cardiovascular Disease 2018-2026 ($ Million)
Table 40 North America Diagnostic Market In Autoimmune Diseases 2018-2026 ($ Million)
Table 41 Selected Infectious Etiologies of Autoimmune Diseases
Table 42 North America Diagnostic Market In Diabetes Mellitus 2018-2026 ($ Million)
Table 43 North America Diagnostic Market In Nephrological Diseases 2018-2026 ($ Million)
Table 44 North America Immunohistochemistry Market In Drug Testing 2018-2026 ($ Million)
Table 45 North America Immunohistochemistry Market By End-Users 2018-2026 ($ Million)
Table 46 North America Immunohistochemistry Market In Hospitals And Diagnostic Laboratories 2018-2026 ($ Million)
Table 47 North America Immunohistochemistry Market In Research Institutes 2018-2026 ($ Million)
Table 48 Cancer Research Program
Table 49 North America Immunohistochemistry Market In Other End-Users 2018-2026 ($ Million)
Table 50 Immunohistochemistry Usage In Forensic Pathology
Table 51 Antibodies Manufacturers In The North America Immunohistochemistry Market
Table 52 North America Immunohistochemistry Market 2018-2026 ($ Million)
Table 53 North America Immunohistochemistry Market 2018-2026 ($ Million)
Table 54 Fund Invested For Different Cancer Types (2017)
Table 55 Percent Distribution of Projected New Cancer Cases (2017)
Figures List
Figure 1 North America Immunohistochemistry Market 2018-2026 ($ Million)
Figure 2 North America Immunohistochemistry Market In Antibodies 2018-2026 ($ Million)
Figure 3 North America Immunohistochemistry Market In Equipment 2018-2026 ($ Million)
Figure 4 North America Immunohistochemistry Market In Reagents 2018-2026 ($ Million)
Figure 5 Phases of Histological Staining
Figure 6 North America Immunohistochemistry Market In Kits 2018-2026 ($ Million)
Figure 7 North America Immunohistochemistry Market In Diagnostic 2018-2026 ($ Million)
Figure 8 North America Immunohistochemistry Market In Drug Testing 2018-2026 ($ Million)
Figure 9 North America Immunohistochemistry Market In Hospitals And Diagnostic Laboratories 2018-2026 ($ Million)
Figure 10 North America Immunohistochemistry Market In Research Institutes 2018-2026 ($ Million)
Figure 11 North America Immunohistochemistry Market In Other End-Users 2018-2026 ($ Million)
Figure 12 History of Immunohistochemistry
Figure 13 North America Immunohistochemistry Market 2018-2026 ($ Million)
Figure 14 The United States Immunohistochemistry Market 2018-2026 ($ Million)
Figure 15 Canada Immunohistochemistry Market 2018-2026 ($ Million)
  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs